Transthyretin: A review from a structural perspective

Cellular and Molecular Life Sciences

Volumn 58, Issue 10, 2001, Pages 1491-1521

  Hamilton, J A ^a   Benson, M D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Amyloid; Retinol; Structure; Throxine; Transthyretin; Vitamin A

Indexed keywords

PREALBUMIN; RETINOL; RETINOL BINDING PROTEIN; THYROXINE;

AMINO ACID SUBSTITUTION; AMYLOIDOSIS; BINDING SITE; DISEASE MODEL; GENE SEQUENCE; GENETIC RISK; HETEROZYGOTE; HUMAN; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSGENIC MOUSE; X RAY ANALYSIS;

EID: 0034799733     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000791     Document Type: Review

References (208)

1. The amino acid sequence of human plasma prealbumin
2. Structure and function of thyroxine transport proteins
3. IUB-IUPAC Joint Commission on Biochemical Nomenclature
4. Cellular origin of prealbumin in the rat
5. Analyses of prealbumin mRNAs in individuals with familial amylodotic polyneuropathy
6. Structure and expression of the mouse prealbumin gene
7. Transthyretin: A choroids plexus-specific transport protein in human brain
8. The concentration of prealbumin in cerebrospinal fluid, indicator of CSF circulation disorders
9. High prealbumin and transferring mRNA levels in the choroid plexus of rat brain
10. The mammalian pineal is a synthetic site for transthyretin and retinal-binding protein
11. Immunohisochemical localization of plasma retinol-binding protein and prealbumin in human pancreatic islets
12. Sites of prealbumin production in the human fetus using indirect immunoperoxidase technique
13. Influence of age and sex on prealbumin levels
14. Radioimmunoassay for human thyroxine-binding prealbumin
15. Rat plasma prealbumin: Isolation and partial characterization
16. Metabolism of prealbumin in rats and changes induced by acute inflammation
17. Transthyretin (prealbumin) in health and disease: Nutritional implications
18. Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at-risk relatives
19. Kristallisation des prealbumins aus humanserum
20. An X-ray study of the subunit structure of prealbumin
21. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8A
22. Thyroxine transport proteins of plasma: Molecular properties and biosynthesis
23. Transport of thyroid hormones in serum and cerebrospinal fluid
24. Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates
25. Pathophysiological aspects of plasma protein formation in the choroid plexus
26. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus
27. Transthyretin expression in the rat brain: Effect of thyroid functional state and role in thyroxine transport
28. Preparation of crystalline thyroxine-binding prealbumin from human plasma
29. X-ray analysis of thyroid hormone binding to prealbumin
30. Thyroxine-binding proteins
31. Studies on thyroid hormone-binding proteins
32. Negative cooperativity in the binding of thyroxine to human serum prealbumin
33. Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonapthalene-1-sulfonate fluorescence
34. Protein-DNA and protein-hormone interactions in prealbumin: A model of the thyroid hormone nuclear receptor?
35. X-ray crystallographic studies of thyroid hormone analogue and competitor binding interactions with human serum prealbumin
36. 3 with prealbumin
37. Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin
38. Mechanism of molecular recognition: Structural aspects of 3,3′-diiodo-L-thyronine binding to human serum transthyretin
39. Crystal structure determination at 2.3 Å resolution of human transthyretin-3′, 5′-dibromo-2′,4,4′,6-tetrahydroxyaurone complex
40. Reduced affinity for thyroxine in two of three structural thyroxine-binding prealbumin variants associated with familial amyloidotic polyneuropathy
41. The molecular basis of dyspreal-buminemic hyperthyroxinemia: Identification of a point mutation in transthyretin that increases affinity for thyroxine
42. Hyperthyroxinemia due to the co-existence of two raised affinity thyroxine-binding proteins (albumin and prealbumin) in one family
43. An Inherited non-amyloidogenic transthyretin variant, (Ser6)-TTR, with increased thyroxine-binding affinity characterized by DNA sequencing
44. Production and functional analysis of normal and variant recombinant human transthyretin proteins
45. Tetramer formation of a variant type human transthyretin (prealbumin) produced by Escherichia coli expression system
46. Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP)
47. Thyroxine interactions with transthyretin a comparison of 10 different naturally occurring human transthyretin variants
48. X-ray analysis of thyroid hormone binding to prealbumin
49. Alteration in molecular structure which results in disease: The Met 30 variant of human plasma transthyretin
50. Thyroxine binding in a TTR Met 119 kindred
51. Biochemical and clinical characterization of a prealbumin (CHICAGO): An apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis
52. A novel variant of transthyretin (prealbumin), Thr119 to Met, associated with increased thyroxine binding
53. Thyroxine binding by human transthyretin variants mutations at position 119, but not position 54, increase thyroxine-binding affinity
54. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy
55. Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin
56. Polymorphism of human thyroxine-binding prealbumin
57. Modifications of transthyretin in amyloid fibrils analysis of amyloid from homozygous and heterozygous individuals with the Met 30 mutation
58. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis
59. The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val30 → Met variant to 1.7 Å resolution
60. X-ray crystal structure of the Ala 109 → Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia
61. Comparison of the modeled thyroxine-binding site in TBG with the experimentally determined site in transthyretin
62. Crystal structure of the transthyretin-retinoic-acid complex
63. Extraction and recombination studies of the interaction of retinol with human plasma retinol-binding protein
64. The binding stoichiometry of human plasma retinol-binding protein to prealbumin
65. The interaction of human serum retinol-binding protein with prealbumin
66. On the stoichiometry of the interaction between prealbumin and retinol-binding protein
67. Crystallographic refinement of human serum retinol binding protein at 2 Å resolution
68. Crystal structure of liganded and unliganded forms of bovine plasma retinol-binding protein
69. Crystal structure of the trigonal form of human plasma retinol-binding protein at 2.5 Å resolution
70. Structural changes in transthyretin produced by the Ile 84 Ser mutation which results in decreased affinity for retinol-binding protein
71. The Ile-84 → Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein
72. Low plasma concentrations of retinol-binding protein in individuals with mutations affecting position 84 of the transthyretin molecule
73. Structure of a complex of two plasma proteins transthyretin and retinol-binding protein
74. The crystal structure of transthyretin from chicken
75. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP
76. Role of the C-termini of human and chicken plasma retinol-binding proteins
77. The interaction between retinol-binding proteins and prealbumins by fluorescence polarization
78. Studies on two physiological forms of the human retinol-binding protein differing in vitamin A and arginine content
79. Review: The transthyretin-retinol-binding protein complex
80. Electron microscopic observation on a fibrous component in amyloid of diverse origins
81. On the binding of Congo red by amyloid
82. The prealbumin nature of the amyloid protein in familial amyloidotic polyneuropathy (FAP)
83. The nature of amyloid
84. X-ray diffraction studies of amyloid filaments
85. The relation of the properties of congo red-stained amyloid fibrils to the conformation
86. Amyloid deposits and amyloidosis: The β-fibrilloses
87. Three forms of dominant amyloid neuropathy
88. Amyloidosis
89. A peculiar form of peripheral neuropathy: Familial atypical generalized amyloidosis with special involvement of the peripheral nerves
90. Ocular manifestations of hereditary primary systemic amyloidosis
91. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
92. Characterization of a prealbumin variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss)
93. Transthyretin amyoidosis
94. Cloning and sequence analysis of cDNA for human prealbumin
95. Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques
96. Localization of the human prealbumin gene to chromosome 18
97. Structure of the human prealbumin gene
98. Structure of the chromosome gene for human serum prealbumin
99. Biochemical and molecular genetic characteristic of a new variant prealbumin associated with hereditary amyloidosis
100. Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1
101. Localization of the human prealbumin gene to 18p11.1-q12.3 by gene dose effect study of Southern blot hybridization
102. Transcriptional control of the mouse prealbumin (transthyretin) gene: Both promoter sequences and a distinct enhancer are cell specific
103. Structural comparisons between mouse and human prealbumin
104. Structure and expression of the rat transthyretin (prealbumin) gene
105. 1-antitrypsin and transthyretin genes
106. Purified hepatocyte nuclear factor I interacts with a family of hepatocyte-specific promoters
107. Structure and expression of the mutant prealbumin gene associated with familial amyloidotic polyneuropathy
108. Brain-specific expression of transthyretin mRNA as revealed by cDNA cloning from brain
109. Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy
110. Paraffin oil protection of substitutions of neutral amino acids in denatured proteins the case of four human transthyretin (prealbumin) variants associated with familial amyloidotic polyneuropathy
111. Familial amyloidotic polyneuropathy diagnosed by cloned human prealbumin cDNA
112. Prenatal detection of a gene for hereditary amyloidosis
113. Hereditary amyloidosis detection of variant prealbumin genes by restriction enzyme analysis of amplified genomic DNA sequences
114. Prenatal diagnosis of hereditary amyloidosis in a Portuguese family
115. The single proline-glutamine substitution at position 5 enhances the potency of amyloid fibril formation of murine apo A-II
116. A new murine model of accelerated senescence
117. Generation of transgenic mice producing a human transthyretin variant: A possible mouse model for familial amyloidotic polyneuropathy
118. Tissue-specific and developmental expression of human transthyretin gene in transgenic mice
119. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene
120. Transgenic mouse model of familial amyloidotic polyneuropathy
121. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene
122. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study
123. A transgenic mouse line developed to express human amyloidogenic transthyretin cDNA in the brain
124. Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice
125. Amyloidosis: Some recent developments
126. Human serum amyloid P component
127. Isolation and characterization of the complete complementary and genomic DNA sequences of human serum amyloid P component
128. Structure of the mouse serum amyloid P component gene
129. Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene
130. Generation of TTR deficient mice by gene targeting
131. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinal and thyroid hormone
132. Thyroid hormone metabolism in a transthyretin-null mouse strain
133. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy
134. A 6-kb upstream region of the human transthyretin gene can direct developmental, tissue-specific, and quantitatively normal expression in transgenic mouse
135. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination
136. Interactions of retinol with binding proteins studies with retinol-binding protein and with transthyretin
137. Retinol metabolism in rats with low vitamin A status: A compartmental model
138. Lipoprotein lipase hydrolysis of retinyl ester
139. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin
140. Retinol binding protein and transthyretin are secreted as a complex formed in the endoplasmic reticulum in HepG2 human hepatocarcinoma cells
141. Senile cardiac amyloid is related to prealbumin
142. Frequency and distribution of senile cardiovascular amyloid: A clinicopathologic correlation
143. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin
144. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin
145. Familial amyloidotic polyneuropathy
146. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type)
147. Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan. III. Analysis of amyloid fibril protein
148. Different types of microheterogeneity of human thyroxine-binding prealbumin
149. Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy
150. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy
151. Structure of Met 30 variant of transthyretin and its amyloidogenic implications
152. Intermolecular disulfide linkages are not required for transthyretin amyloid fibril formation in vitro
153. Senile systemic amyloidosis
154. Fibril in senile systemic amyloidosis is derived from normal transthyretin
155. The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis
156. Enhanced amyloidogenicity of sulfonated transthyretin in vitro, a hypothetical etiology of senile amyloidosis
157. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis
158. Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis
159. Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro
160. Structural analysis of peptide fragment 71-93 of transthyretin by NMR spectroscopy and electron microscopy: Insight into amyloid fibril formation
161. Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy
162. Systemic senile amyloidosis: Identification of a new prealbumin (transthyretin) variant in cardiac tissue. Immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy
163. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation
164. Mechanism of transthyretin amyloidogenesis: Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations
165. Biochemical effects of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-net30)
166. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
167. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation
168. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
169. Liver transplant halts the progress of familial amyloidotic polyneuropathy
170. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro
171. Transthyretin acid induced denaturation is required for amyloid fibril formation in vitro
172. Genetic analysis of protein folding pathways
173. Amyloid proteins, precursors mediator, and enhancer
174. Intralysosomal formation of amyloid fibrils
175. Amyloid enhancing factor-loaded macrophages in amyloid formation
176. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation
177. Detergent assisted refolding of GU-HCL-denatured rhodanese
178. Detergent assisted refolding of guanidinium chloride-denatured rhodanese
179. Characterization of the transthyretin acid denaturation pathways by analytical ultrcentrifugation: Implication for wild-type, V30M, and L55P amyloid fibril formation
180. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid
181. Classification of acid denaturation of proteins: Intermediates and unfolded states
182. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface
183. Characterization of two highly amyloidogenic mutants of transthyretin
184. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry
185. Comparative calorimetric study of non-amyloigenic and amyloidogenic variants of the homotetrameric protein transthyretin
186. The preaggregated state of an amyloidogenic protein: Hydrostatic pressure converts native transthyretin into the amyloidogenic state
187. Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants
188. 55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils
189. The β-slip: A novel concept in transthyretin amyloidosis
190. The kinetics of amyloid deposition: I. The effect of amyloid-enhancing factor and splenectomy
191. Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: New model for amyloid fibril formation
192. Analysis of X-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: Axially arrayed TTR monomers constitute the protofilament
193. The tetrameric protein transthyretin dissociates to a non-native monomer in solution
194. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution
195. History of the amyloid fibril
196. TTR amyloidosis - Structural features leading to protein aggregation and their implications on therapeutic strategies
197. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation
198. Electron microscopy of amyloid
199. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix
200. Tertiary structure of an amyloid immunoglobulin light chain protein: A proposed model for amyloid fibril formation
201. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-Å resolution
202. Crystal and molecular structure of the dimer of variable domains of the Bence-Jones protein ROY
203. A high resolution ultrastructural study of experimental murine AA amyloid
204. 2-microglobulin amyloid fibrils
205. Ultrastructural organization of connective tissue microfibrils in the posterior chamber of the eye in vivo and in vitro
206. Ultrastructural and immunohistochemical studies of microfibril-associated components in the posterior chamber of the eye
207. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
208. The protein data bank